Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172551 | SCV000051393 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037337 | SCV000060994 | likely benign | not specified | 2015-04-18 | criteria provided, single submitter | clinical testing | p.Arg538Cys in exon 13 of LAMA4: This variant is not expected to have clinical s ignificance because it has been identified in 0.3% (19/6614) of Finnish chromoso mes and 0.2% (153/66734) of European chromosomes by the Exome Aggregation Consor tium (ExAC, http://exac.broadinstitute.org; dbSNP rs138153075). |
Gene |
RCV000172551 | SCV000250553 | likely benign | not provided | 2021-02-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000206650 | SCV000262235 | likely benign | Dilated cardiomyopathy 1JJ | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620865 | SCV000737176 | benign | Cardiovascular phenotype | 2020-12-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770220 | SCV000901650 | likely benign | Cardiomyopathy | 2016-11-23 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000853004 | SCV000995759 | likely benign | Hypertrophic cardiomyopathy; Ventricular tachycardia | 2019-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000206650 | SCV001157646 | likely benign | Dilated cardiomyopathy 1JJ | 2023-08-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000172551 | SCV004160013 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | LAMA4: BP4, BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037337 | SCV004223366 | likely benign | not specified | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000206650 | SCV000734449 | likely benign | Dilated cardiomyopathy 1JJ | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000172551 | SCV001798872 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037337 | SCV001920204 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000172551 | SCV001930111 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037337 | SCV001954225 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172551 | SCV001972648 | likely benign | not provided | no assertion criteria provided | clinical testing |